8 Chronic Obstructive Pulmonary Disease (COPD) Nursing Care Plans

What is Chronic Obstructive Pulmonary Disease (COPD)?

Chronic Obstructive Pulmonary Disease (COPD) is a common, preventable, and treatable disease marked by persistent respiratory symptoms and airflow limitation from airway and/or alveolar abnormalities, usually caused by significant exposure to noxious particles or gases. It presents with chronic dyspnea, cough, sputum production, and exacerbations driven by abnormalities of the airways (bronchitis) and/or alveoli (emphysema). The CDC reports that about 3.8% of US adults had diagnosed COPD in 2023, with prevalence rising sharply with age to 10.5% in adults 75 and older (CDC NCHS, 2023).

Chronic inflammation and abnormal inflammatory responses to harmful particles or gases narrow the airways and change the lung parenchyma and pulmonary vasculature. The airways develop increased mucus production, thickened walls, and overall narrowing. The parenchyma loses alveolar walls and elastic recoil. Imbalances of substances such as proteinases add to the airflow limitation. Chronic inflammation, environmental exposures, and genetic factors like alpha1-antitrypsin deficiency all drive these changes.

Asthma: Also called chronic reactive airway disease. Reversible inflammation and constriction of bronchial smooth muscle, mucus hypersecretion, and edema. Triggers include allergens, emotional upheaval, cold weather, exercise, chemicals, medications, and viral infections.

Chronic bronchitis: Widespread airway inflammation with narrowing or blocking of airways, increased mucoid sputum, and marked cyanosis.

Emphysema: The most severe form. Recurrent inflammation damages and destroys alveolar walls, creating large blebs or bullae and collapsed bronchioles on expiration (air-trapping).

Suspect COPD in any client with dyspnea, chronic cough or sputum production, a history of recurrent lower respiratory tract infections, and/or exposure to risk factors. Forced spirometry showing a post-bronchodilator FEV1/FVC <0.7 is mandatory to confirm the diagnosis, per the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2025 report. With that ratio established, severity is graded on the post-bronchodilator FEV1:

• GOLD 1: Mild (FEV1 >80% predicted)
• GOLD 2: Moderate (50% ≤ FEV1 <80% predicted)
• GOLD 3: Severe (30% ≤ FEV1 <50% predicted)
• GOLD 4: Very severe (FEV1 <30% predicted)

Most COPD clients are managed outpatient, so build a teaching plan that helps them stick to therapy and understand a chronic, progressive disease.

Nursing Care Plans & Management

Care centers on teaching and improving the client's respiratory status.

Nursing Problem Priorities

1. Maintain airway patency.
2. Facilitate gas exchange.
3. Enhance nutritional intake.
4. Prevent complications and slow progression.
5. Provide information about the disease process, prognosis, and treatment.

Nursing Assessment

COPD brings chronic cough, sputum production, and worsening dyspnea, and it can drive weight loss and respiratory complications. Advanced stages change the thorax and produce systemic effects.

Assess for the following subjective and objective data:

• Difficulty breathing
• Changes in depth/rate of respirations, use of accessory muscles
• Abnormal breath sounds (wheezes, rhonchi, crackles)
• Persistent cough, with or without sputum production
• Confusion, restlessness
• Inability to move secretions
• Abnormal ABG values (hypoxia and hypercapnia)
• Changes in vital signs
• Reduced activity tolerance
• Wheezes/crackles on auscultation in both lung fields
• Subcostal retraction
• Nasal flaring
• Tachypnea, dyspnea, exertional dyspnea
• Shortness of breath

Assess for factors related to the cause of COPD:

• Bronchospasm
• Increased, retained, or thick viscous secretions
• Hyperplasia of bronchial walls
• Decreased energy/fatigue
• Altered oxygen supply (airway obstruction by secretions, bronchospasm, air-trapping)
• Alveoli destruction or capillary membrane changes
• Ineffective inspiration and expiration with chronic airflow constraints
• Increased metabolic demands

Nursing Diagnosis

After assessment, formulate a nursing diagnosis that fits the client's condition and your clinical judgment. Diagnostic labels organize care, but in practice your judgment shapes the plan around each client's priorities.

Nursing Goals

Goals and expected outcomes may include:

• The client will maintain clear, patent airways with effective breath sounds and the ability to cough and clear secretions.
• The client will achieve improved ventilation and tissue oxygenation, shown by ABG values within normal range and absence of respiratory distress.
• The client will demonstrate improved breathing patterns, maintain a normal respiratory rate, and stay free of cyanosis and other signs of hypoxia.

Nursing Interventions and Actions

1. Maintaining Patent Airway Clearance

Bronchospasm is common to many pulmonary diseases. It narrows the small bronchi and causes difficulty breathing, stasis of secretions, and infection. Mucous gland hyperplasia is the histologic hallmark of chronic bronchitis. Airway structural changes (atrophy, focal squamous metaplasia, ciliary abnormalities, smooth muscle hyperplasia, inflammation, bronchial wall thickening) deform the airway walls and narrow the lumen.

Assess and monitor respirations and breath sounds, noting rate and sounds (tachypnea, stridor, crackles, wheezes). Note the inspiratory-to-expiratory ratio. Tachypnea is usually present and may worsen on admission, during stress, or with concurrent infection. Respirations may be shallow and rapid with prolonged expiration. Wheezing is often heard on forced and unforced expiration with diffusely decreased breath sounds, and coarse crackles may begin with inspiration.

Auscultate breath sounds. Note adventitious sounds (wheezes, crackles, rhonchi). Bronchospasm with airway obstruction may produce scattered moist crackles (bronchitis), faint sounds with expiratory wheezes (emphysema), or absent breath sounds (severe asthma). Wheezes and chest tightness can vary between days and within a single day.

Note the presence and degree of dyspnea, including reports of "air hunger" or breathlessness. Chronic dyspnea is the most characteristic symptom of COPD. The modified Medical Research Council (mMRC) dyspnea scale measures this breathlessness.

Watch for signs and symptoms of infection. Acute exacerbations are common and usually follow a trigger such as bacterial or viral pneumonia or environmental irritants, with increased inflammation and air trapping that often require corticosteroid and bronchodilator treatment.

Monitor and graph serial ABGs, pulse oximetry, and chest x-ray. This sets a baseline for tracking the disease. ABG analysis gives the best read on the acuteness and severity of an exacerbation. In emphysema, chest films show hyperinflation: flattened diaphragm, increased retrosternal air space, and a long, narrow heart shadow. Chronic bronchitis shows increased bronchovascular markings and cardiomegaly.

Watch for a persistent, hacking, or moist cough. Chronic cough is often the first symptom and is frequently dismissed by the client as a consequence of smoking or exposures. It may start intermittent, then occur daily. It can be productive or unproductive, and significant obstruction can develop without any cough.

Educate the client on smoking cessation. Many clients keep smoking despite their diagnosis, which worsens prognosis and progression. Cessation has the greatest power to change the natural history of COPD. With dedicated resources and time, long-term quit rates of up to 25% are achievable.

Provide an incentive spirometer to measure airflow obstruction. Forced spirometry is the most reproducible and objective measure of airflow obstruction. It is noninvasive, cheap, and available in any setting. The GOLD criterion for obstruction is a post-bronchodilator FEV1/FVC <0.7.

Help the client into a position of comfort (elevate the head of the bed, lean on an overbed table, or sit on the edge of the bed). Elevating the head of the bed uses gravity to ease breathing, and the client in severe distress will seek the position that helps most. Supporting the arms and legs with a table and pillows reduces muscle fatigue and aids chest expansion.

Keep environmental pollution to a minimum (dust, smoke, feather pillows) per the situation. These trigger or worsen an acute episode. COPD also occurs in people who never smoked; biomass fuels for indoor cooking and heating and long-term traffic-related air pollution are contributors.

Encourage abdominal or pursed-lip breathing. This gives the client a way to control dyspnea and reduce air trapping. Breathing exercises improve respiratory muscle strength and endurance, correct abnormal chest and abdomen movement, and reduce dyspnea and dynamic hyperinflation.

Help improve the effectiveness of the cough. Cough can be persistent but ineffective, especially in older, acutely ill, or debilitated clients. It works best upright or head-down after chest percussion. Controlled coughing uses just enough force to move mucus without collapsing the airways, which saves energy.

Increase fluid intake to 3000 mL per day within cardiac tolerance. Provide warm or tepid liquids. Offer fluids between meals rather than during. Hydration thins secretions and aids expectoration. Warm liquids may decrease bronchospasm. Fluids with meals increase gastric distension and pressure on the diaphragm.

Demonstrate effective coughing and deep-breathing technique. Explosive, uncontrolled coughing collapses and spasms airways, trapping mucus. Have the client sit and lean slightly forward, fold both arms across the abdomen, inhale slowly through the nose, then cough two or three times through a slightly open mouth with short, sharp coughs.

Turn the client every 2 hours. If ambulatory, allow ambulation as tolerated. Movement mobilizes secretions and helps clear the airways. Aerobic activity such as walking strengthens large muscle groups and builds endurance even though it does not directly improve lung function.

Suction secretions as needed. Clearing obstructing secretions improves oxygenation. During invasive ventilation in respiratory failure with advanced exacerbation, bronchoscopic sputum suction can outperform negative-pressure suction with a low mortality rate.

Demonstrate chest physiotherapy, such as bronchial tapping during cough and proper postural drainage. These prevent aspiration and complications. As part of pulmonary rehabilitation, postural drainage and deep breathing-coughing exercises increase oxygen saturation, triFlo volume, and pulmonary function.

Administer medications as prescribed. See pharmacologic interventions below.

2. Promoting Effective Gas Exchange & Oxygen Therapy

Thick, abundant sputum obstructs the airway and impairs ventilation and gas exchange. Emphysema permanently enlarges the airspaces distal to the terminal bronchioles, cutting the alveolar surface area for gas exchange. Loss of alveolar walls decreases elastic recoil, and loss of supporting structure narrows the airways, both limiting airflow.

Assess and record respiratory rate and depth. Note accessory muscle use, pursed-lip breathing, and inability to speak. This gauges the degree of respiratory distress. Respiratory rate rises with disease severity. Accessory muscle use with paradoxical indrawing of the lower intercostal spaces is the Hoover sign.

Assess and routinely monitor skin and mucous membrane color. Cyanosis may be peripheral (nail beds) or central (lips, earlobes); duskiness and central cyanosis indicate advanced hypoxemia. Clients with chronic bronchitis are called "blue bloaters" because the body decreases ventilation and increases cardiac output, producing a ventilation/perfusion mismatch, hypoxemia, and polycythemia, with eventual hypercapnia and respiratory acidosis that tints the skin blue.

Monitor level of consciousness and mental status. Restlessness, agitation, and anxiety are common signs of hypoxia. Worsening ABGs with confusion or somnolence point to cerebral dysfunction from hypoxemia. Depression and anxiety are common in COPD, worsen health status and exacerbation risk, and are treatable.

Monitor vital signs and cardiac rhythm. Tachycardia, dysrhythmias, and BP changes reflect systemic hypoxemia affecting cardiac function. Chronic bronchitis may show right-sided heart failure with edema and cyanosis. Emphysema may produce distant heart sounds from destruction of alveolar septae and the pulmonary capillary bed, lowering cardiac output.

Auscultate breath sounds, noting decreased airflow and adventitious sounds. Breath sounds may be faint from decreased airflow or consolidation. Wheezes may signal bronchospasm or retained secretions; scattered moist crackles may indicate interstitial fluid or cardiac decompensation.

Palpate for fremitus. Decreased vibratory tremors suggest fluid collection or air-trapping. Decreased tactile fremitus occurs with hyperinflation, common in emphysema, COPD, asthma, or severe airway obstruction.

Monitor SpO2 and titrate oxygen to maintain SpO2 between 88% to 92%. A reading of 87% or below may indicate the need for oxygen; 92% or higher may require titration. Pulse oximetry gives less information than ABG analysis but, combined with clinical observation, gives instant feedback on status.

Monitor arterial blood gas values as ordered. ABG analysis gives the best read on the severity of an exacerbation. As the disease progresses, PaO2 usually falls. A client with chronic CO2 retention may have chronically compensated respiratory acidosis with a low-normal pH and a PaCO2 higher than 50 mm Hg. Renal compensation usually keeps pH near normal; any pH below 7.3 signals acute respiratory compromise.

Evaluate activity tolerance. Fatigue is one of the most common and distressing COPD symptoms and limits activities of daily living and quality of life.

Assess sputum characteristics. Sputum can be intermittent, with flare-ups between periods of remission. COPD clients usually raise small quantities of tenacious sputum. Large volumes suggest underlying bronchiectasis. Purulent sputum reflects increased inflammatory mediators and may mark a bacterial exacerbation.

Encourage expectoration of sputum; suction when needed. Thick, copious secretions are a major source of impaired gas exchange in small airways. Deep suctioning may be required when cough is ineffective. In acute exacerbation, retained sputum causes severe obstruction, atelectasis, and infection. Blind negative-pressure aspiration can damage airway mucosa; bronchoscopic removal is more precise.

Elevate the head of the bed and help the client into a position that eases the work of breathing. Include periods of prone positioning as tolerated. Upright positioning and breathing exercises decrease airway collapse, dyspnea, and work of breathing. Prone positioning can lower airway resistance in highly obstructed clients.

Encourage deep, slow, or pursed-lip breathing as tolerated. Pursed-lip breathing increases oxygen saturation in moderate to severe COPD. Pulmonary rehabilitation pairs it with education, psychosocial support, and aerobic and breathing exercises for early treatment of exacerbations.

Provide a calm, quiet environment. Limit activity or encourage bed or chair rest during the acute phase, then resume activity gradually as tolerated. In severe or refractory respiratory distress, the client may be unable to perform basic self-care because of hypoxemia and dyspnea. Rest between care activities is essential. A graded exercise program builds endurance and strength without provoking severe dyspnea.

Evaluate sleep patterns; note difficulties and whether the client feels rested. Limit stimulants such as caffeine. External stimuli and dyspnea prevent relaxation and inhibit sleep. Poor sleep quality affects 40% to 75% of COPD clients, and cough and dyspnea are common causes.

Provide humidified oxygen as ordered. Humidified oxygen prevents drying of the airways, decreases moisture losses, and improves compliance. Oxygen reduces mortality in advanced COPD through favorable effects on pulmonary hemodynamics. The continuous-flow nasal cannula is the standard delivery for the stable hypoxemic client and works for most mouth-breathers.

Administer noninvasive positive pressure ventilation (NIPPV) as ordered. NIPPV can decrease PaCO2, raise blood pH, and ease severe dyspnea within the first 4 hours of treatment. It delivers positive-pressure ventilation through a tight-fitting nasal or facial mask attached to a CPAP or BiPAP machine instead of an endotracheal tube.

Refer the client to pulmonary rehabilitation. Rehabilitation started during hospitalization or within 4 weeks after discharge reduces mortality and improves dyspnea, health status, and exercise tolerance in stable clients.

Assist with surgical procedures such as lung transplantation and lung volume reduction surgery (LVRS). In LVRS, 20 to 30% of each lung that appears most diseased is resected; removing emphysematous lung increases radial traction on the remaining airways and improves expiratory airflow. LVRS has shown benefits in spirometry, exercise tolerance, dyspnea, quality of life, and mortality in selected clients. COPD clients are the largest single group undergoing lung transplantation, which is aimed at improving symptoms and quality of life.

3. Improving Breathing Pattern Through Breathing Exercises

Shortness of breath and ineffective breathing patterns come from poor respiratory mechanics: air trapping, ineffective diaphragmatic movement, airway obstruction, the metabolic cost of breathing, and stress. As metabolic demand rises, so does respiratory rate.

Assess respiratory status every 2 to 4 hours and report abnormal findings. Respiratory distress shows as shortness of breath, tachypnea, mental status changes, and accessory muscle use. Chronic dyspnea is the most characteristic symptom and may precede airflow obstruction by years.

Auscultate breath sounds as indicated. Decreased breath sounds, crackles, wheezes, and rhonchi must be reported promptly. Emphysema may produce a hyper-resonant chest with wheezing; chronic bronchitis produces coarse rhonchi and wheezing.

Monitor for a synchronous respiratory pattern on a mechanical ventilator. Difficulty breathing with the ventilator or rising airway pressures suggests worsening or complications. In centers with extensive NIPPV experience, COPD clients can be considered for early extubation to NIPPV.

Assess ventilator settings routinely and readjust as indicated. Settings are adjusted to the client's disease and diagnostic results. Noninvasive ventilation usually starts at low pressures, IPAP 8 to 10 cm H2O and EPAP 4 to 5 cm H2O, and increases with clinical status.

Elevate the head of the bed. This allows lung expansion during sleep, decreases aspiration risk while on a ventilator, and helps psychologically. Prone positioning can reduce resistance if it does not interfere with the client's condition.

Teach the client to splint the chest wall with a pillow during coughing as appropriate. This eases maximal inspiration. During controlled coughing, the client folds both arms across the abdomen and breathes in slowly through the nose before coughing two or three times through a slightly open mouth.

Promote deep breathing exercises such as diaphragmatic, yoga, and pursed-lip breathing. Pursed-lip breathing helps control sudden acute symptoms during dyspnea, anxiety, or panic. Yoga breathing (pranayama) uses varied patterns and breath-holds to strengthen breathing.

Maintain a patent airway. Suction secretions as ordered. Bronchoscopic sputum suction shortens the time of invasive ventilation and hospital stay and improves weaning success.

Check tubing for obstruction, kinking, or water accumulation. Drain tubing as indicated. Kinks prevent adequate volume delivery and raise airway pressure. Condensation prevents proper gas distribution and promotes bacterial growth.

Encourage participation in pulmonary rehabilitation. Rehabilitation improves quality of life by decreasing airflow limitation, preventing complications, and relieving symptoms through education, smoking cessation, medical management, chest physiotherapy, exercise, and psychosocial support.

Administer oxygen supplementation as indicated. Long-term oxygen therapy improves survival 2-fold or more in hypoxemic COPD clients. It is recommended for clients with a PaO2 less than 55 mm Hg, or a PaO2 less than 59 mm Hg with polycythemia or cor pulmonale. Oxygen during exercise can prevent rises in pulmonary artery pressure, reduce dyspnea, and improve exercise tolerance.

Start noninvasive mechanical ventilation when indicated. Noninvasive ventilation should be the first mode in COPD clients with acute respiratory failure and no absolute contraindication. It improves gas exchange, reduces work of breathing and need for intubation, shortens hospitalization, and improves survival.

Administer medications as prescribed. See pharmacologic interventions below.

4. Administering Medications and Pharmacological Support

Medication regimens are matched to disease severity. Mild COPD may need only a short-acting bronchodilator. Moderate to severe disease needs regular short-acting plus long-acting bronchodilators. Severe or very severe disease may need bronchodilators and/or inhaled corticosteroids to control exacerbations.

Bronchodilators Bronchodilators widen the airways, improve lung emptying, and relieve bronchospasm. Inhaled therapy is preferred, with the choice guided by response and side effects. Long-acting agents are more convenient and may be combined for symptom control. They do not change disease progression or prognosis but are central to management. Inhaler technique and training are essential, and device choice depends on availability, cost, prescription, and client skill. Bronchodilators may be used prophylactically before activity to prevent breathlessness. Classes include beta-adrenergic agonists, muscarinic antagonists, and combination agents, which can be combined to enhance bronchodilation. Nebulized medications are an option for clients who cannot use inhalers.

Antimuscarinic drugs These block the bronchoconstrictor effect of acetylcholine on M3 muscarinic receptors in airway smooth muscle. Short-acting antimuscarinics (SAMAs) such as ipratropium and oxitropium also block the inhibitory M2 receptor. Long-acting muscarinic antagonists (LAMAs) such as tiotropium, aclidinium, glycopyrronium bromide, and umeclidinium bind M3 receptors longer and dissociate faster from M2, prolonging bronchodilation.

Mucolytics Regular treatment with mucolytics such as carbocysteine and N-acetylcysteine may reduce exacerbations and modestly improve health status. They reduce sputum viscosity and improve clearance. Inhaled N-acetylcysteine should be given with a bronchodilator to counter possible bronchospasm.

Oral corticosteroids such as prednisone and methylprednisolone. Oral steroids are widely accepted for acute exacerbations given their efficacy. Corticosteroids decrease inflammation by reversing increased capillary permeability and suppressing PMN activity.

Inhaled corticosteroids such as budesonide (Pulmicort Flexhaler), mometasone (Asmanex Twisthaler), beclomethasone (Qvar RediHaler), and fluticasone (Flovent HFA). In acute exacerbations, steroids improve symptoms and lung function. Inhaled forms deliver directly to the airways with minimal absorption and fewer adverse effects than oral agents, and may slow progression in the subset of clients with rapid decline.

Long-acting bronchodilators such as salmeterol, formoterol, bambuterol, and indacaterol. For more persistent symptoms, a long-acting bronchodilator increases exercise endurance, prevents nocturnal dyspnea, and improves quality of life by relaxing bronchiolar smooth muscle and easing expectoration.

Combination inhaled corticosteroids and bronchodilators such as Symbicort (budesonide with formoterol fumarate), Advair (fluticasone with salmeterol), and Breo (fluticasone furoate with vilanterol trifenatate). Combinations are more effective than any single agent at decreasing exacerbations and improving lung function, though they carry an increased risk of pneumonia. Inhaled corticosteroids (ICS) combined with long-acting bronchodilators (LABA) and long-acting muscarinic agents (LAMA) decrease inflammation, and ICS plus LABA outperforms either drug alone.

5. Promoting Infection Control & Preventing Complications

Minor respiratory infections can be dangerous in COPD. Bronchopulmonary infection must be controlled or prevented to limit inflammatory edema. Chronic colonization of the lower airways is common with S. pneumoniae, H. influenzae, and M. catarrhalis, and P. aeruginosa in severe airway obstruction.

Monitor temperature. Fever may signal infection or dehydration. An exacerbation may produce a low-grade fever, but a fever >101.3°F (>38.5°C) raises suspicion for an alternate diagnosis such as pneumonia.

Reinforce breathing exercises, effective cough, frequent position changes, and adequate fluid intake. These mobilize and expectorate secretions to reduce the risk of pulmonary infection.

Observe the color, character, and odor of sputum. Odorous, yellow, or greenish secretions suggest pulmonary infection. The Bronkotest 5-point chart classifies sputum color, where 1 to 2 are white to light yellow and 3, 4, and 5 are increasingly purulent; greener colors indicate bacterial infection. In acute exacerbation, green sputum has a negative predictive value of 93%, so sputum color can help reduce inappropriate antibiotic use.

Obtain sputum specimens by deep coughing or suctioning for Gram stain, culture, and sensitivity. This identifies the organism and its susceptibility. The pathogens cultured most often during exacerbations are Streptococcus pneumoniae and Haemophilus influenzae.

Monitor the effectiveness of antibiotic therapy. Improvement should occur within 24 to 48 hours. Clients who benefit most have at least two of: increased dyspnea, increased sputum production, and sputum purulence.

Assist the client in disposing of tissues and sputum. This prevents spread of fluid-borne pathogens. Sputum must be disposed of safely even if the client finds it offensive.

Limit visitors; provide masks as indicated. This reduces exposure to infections such as URI. COPD significantly impairs lung defenses, leading to colonization by potentially pathogenic bacteria.

Stress hand hygiene to the client, staff, and family. Hand hygiene reduces transmission, and touching the eyes, nose, or mouth is the most common route. When soap and water are unavailable, use an alcohol-based hand sanitizer with at least 60% alcohol.

Encourage a balance between activity and rest. This reduces oxygen demand, improves resistance to infection, and promotes healing, self-efficacy, and self-competence.

Discuss adequate nutritional intake. Malnutrition lowers resistance to disease. Targeted caloric supplementation improves fat-free mass, physical performance, quality of life, and even lung function in malnourished clients.

Have the client rinse the mouth with water and spit (not swallow), or use a spacer with inhaled corticosteroids. This reduces the local immunosuppressive effect and the risk of oral candidiasis from corticosteroid deposition in the oropharynx.

Administer antimicrobials as indicated. Give for organisms identified by culture and sensitivity, or prophylactically for high risk. Empiric therapy is recommended with evidence of infection such as fever, leukocytosis, or an infiltrate, and should cover likely pathogens given local resistance patterns. Adding doxycycline to corticosteroids has shown some benefit for acute exacerbation.

Educate the client on vaccination. The injectable trivalent inactivated influenza vaccine (seasonal H3N2, H1N1, and influenza B) is given annually and prevents hospitalizations and serious outcomes. The pneumococcal vaccine should be offered to all clients older than 65 years or to any client with an FEV1 less than 40% of predicted. Give the influenza vaccine annually to all COPD clients.

Promote smoking cessation and prevention of environmental pollution. Smoking is the major risk factor for COPD development and progression; smokers decline faster and have higher mortality than non-smokers. Ozone, carbon monoxide, particulate matter, and sulfur dioxide induce oxidative stress and inflammation that injure the airways.

6. Promoting Optimal Nutrition Balance

Nutrition and counseling are core to rehabilitation. Most COPD clients struggle to gain and keep weight: 25 to 40% are underweight and 35% have a severely low fat-free mass index. Low fat-free mass reduces exercise ability and muscle function, so malnutrition needs active recognition and management.

Determine the client's understanding of individual nutritional needs. Assess needs by clinical state (stable or exacerbation), disease severity, and activity level.

Assess socioeconomic status. COPD clients tend to have lower income and education. Smokers in low-income settings buy less and lower-quality food, hurting nutrition status.

Assess dietary habits and recent intake. Note difficulty eating. Evaluate weight and body size. A client in acute respiratory distress is often anorectic from dyspnea, sputum, and medications. Respiratory insufficiency creates a hypermetabolic state with increased caloric needs, so clients are often admitted malnourished. Emphysema clients are often thin with wasted musculature.

Auscultate bowel sounds. Diminished bowel sounds may reflect decreased gastric motility and constipation, a common complication of limited fluid intake, poor food choices, decreased activity, and hypoxemia. 40% of stable COPD clients report constipation and abdominal distention.

Weigh the client daily as indicated. This guides caloric needs, weight goals, and the adequacy of the nutritional plan. On average, clients lose 1.6 kg over six months, and severely malnourished clients lose more.

Give frequent oral care, remove expectorated secretions promptly, and provide a container for disposal. Noxious taste, smell, and sights deter appetite and can produce nausea and vomiting. COPD clients have poorer periodontal health and lower brushing frequency.

Have the client eat high-caloric foods frequently in smaller portions. COPD clients spend extraordinary energy on breathing and need high-caloric meals to maintain weight and muscle mass. Recommended protein intake is 1.0 to 1.2 g/kg body weight/day, rising to 1.2 to 1.5 g/kg body weight/day for malnourished or chronically ill older clients.

Encourage a rest period of 1 hour before and after meals. COPD is often associated with muscle depletion from increased protein degradation and decreased synthesis. Rest around meals reduces mealtime fatigue and increases total caloric intake.

Avoid gas-producing foods such as carbonated beverages. Abdominal distension hampers diaphragmatic movement and increases dyspnea. Gas-producing foods include carbonated beverages; fried, greasy, or heavily spiced foods; fruits such as apples and melons; and vegetables such as broccoli, beans, and cauliflower.

Increase fluid intake (2.5 liters per day or more) as indicated. Avoid caffeine and tea. Fluids thin secretions in clients with chronic sputum production. At least six to eight glasses of water daily helps mobilize and expectorate secretions. Limit coffee and tea, which can interfere with some medications.

Educate the client on the effect of smoking on malnutrition and encourage cessation. Nicotine increases metabolic rate, reduces metabolic efficiency, suppresses appetite, and decreases energy absorption, all driving weight loss. The longer and more severe the addiction, the higher the malnutrition risk, so pair cessation advice with nutrition counseling from early diagnosis.

Encourage physical activity appropriate to the client's condition. Daily activity drops early in COPD and worsens over time. Moderate-to-high regular activity is associated with reduced lung function decline and fewer exacerbations. Monitoring daily step count and activity time is the most valid measure.

Collaborate with a dietician as indicated. The dietician provides nutritional assessment and counseling and can initiate enteral nutrition in clients who are intubated or cannot tolerate oral feeding, matching the method and caloric requirements to the client's needs.

Administer vitamin supplements as indicated. Vitamins A, C, and E exert anti-inflammatory and antioxidant effects that may protect against progression. Vitamin E 400 IU daily for 12 weeks reduces lipid peroxidation, and vitamin A supplementation improves FEV1 and forced vital capacity. Given the prevalence of osteoporosis in COPD, vitamin D also matters and reduces exacerbation rates.

Administer supplemental oxygen during meals as indicated. Oxygen decreases dyspnea and increases energy for eating, enhancing intake. The client may wear the nasal cannula while eating, since eating and digestion require energy.

7. Promoting Rest and Tolerance to Activity

COPD clients have progressive activity and exercise intolerance. Evaluating tolerance and limitations helps build strategies that promote independent ADLs.

Assess the respiratory response to activity, including respiratory rate and depth, oxygen saturation, and accessory muscle use. Clients can become hypoxic with increased activity and may need oxygen to avoid hypoxemia and exacerbations. Many clients who are not hypoxemic at rest desaturate with exertion, so home oxygen is commonly prescribed.

Assess nutritional status. Adequate energy reserves are needed for activity. Muscle wasting and decreased muscle oxidative metabolism impair physical performance and increase mortality, supporting nutritional supplementation alongside exercise training.

Assess the level of activity the client achieves before exertion. Daily activity is reduced early and worsens over time, with important clinical consequences.

Elevate the head of the bed and have the client change position slowly. Elevation maximizes lung expansion and oxygenation. Postural hypotension or cerebral hypoxia can cause dizziness and fainting, so advise slow position changes.

Maintain prescribed activity levels. This builds tolerance and minimizes dyspnea. Moderate-to-high regular activity is associated with reduced lung function decline. Light activity can make the client less sedentary, with the most benefit in those with moderate airway obstruction.

Plan activity progression with the client, including activities they view as essential. Increase activity as tolerated to promote a gradual return to normal levels, improved muscle tone and stamina, self-esteem, and a sense of control.

Provide at least 90 minutes of undisturbed rest between activities. Undisturbed rest reduces oxygen demand and allows recovery. COPD clients have pronounced ventilatory limitation, impaired maximal oxygen uptake, and dyspnea that severely limit exercise capacity and ADLs.

Teach and assist with active ROM exercises. Active ROM builds stamina and avoids complications of limited mobility. Aerobic lower-extremity endurance exercise improves daily activities and reduces dyspnea, and upper-extremity training improves dyspnea and ADLs that use the arms.

Teach energy conservation, such as keeping frequently used items within reach, sitting to do tasks, changing position often, and working at an even pace. These reduce oxygen consumption and prolong activity. The less energy spent per task, the more the client can do across the day.

Teach breathing exercises that enhance capacity, such as diaphragmatic and pursed-lip breathing. These prolong exhalation, decrease CO2 retention, improve the ventilatory pattern, and prevent dynamic airway compression.

Have the client perform a 6-minute walk. The 6-minute walk distance (6MWD) predicts all-cause and respiratory mortality in moderate COPD. Clients who desaturate during the 6MWD have higher mortality than those who do not.

Refer to a pulmonary rehabilitation program if needed. The program teaches nutrition, breathing, relaxation, medication use, and exacerbation avoidance. Rehabilitation started during hospitalization or within 4 weeks after discharge reduces mortality and lowers anxiety and depression.

Administer supplemental oxygen as indicated. Long-term oxygen increases survival in clients with severe resting hypoxemia. In stable COPD with moderate resting or exercise-induced desaturation, long-term oxygen does not lengthen survival or time to first hospitalization or sustain benefit in health status, lung function, or 6MWD.

8. Providing Patient Education & Health Teachings

COPD requires lifelong treatment and daily management, and self-management during stable periods is what halts progression. Clients with the lowest socioeconomic status are at least twice as likely to have poor outcomes, so addressing low health literacy improves quality of life and decreases hospital admissions.

Assess the client's and caregivers' educational level and cognitive ability. COPD clients are often older with low education, literacy, and internet access, so deliver information through channels they can use.

Assess the client's knowledge of the disease. Knowledge drives self-management; the more they understand, the more they make decisions that benefit their health.

Identify individual triggers (dry air, wind, temperature extremes, pollen, tobacco smoke, aerosol sprays, air pollution). These induce or aggravate bronchial irritation, increasing secretions and airway blockage. COPD also occurs in people who never smoked, and traffic-related air pollution is a factor.

Discuss the importance of medical followup, periodic chest x-rays, and sputum cultures. Monitoring lets you adjust the regimen and prevent complications. A client with severe or unstable disease should be seen monthly; a stable client biannually.

Explain and reinforce the disease process. Information decreases anxiety and improves participation. Teaching that improves knowledge helps establish good self-management, reduces exacerbation and complication rates, and improves quality of life.

Encourage the client and caregivers to control triggers at home and work. Educate and involve caregivers and family. The two key points: smoking cessation improves quality of life, and the client must seek medical care early in an exacerbation rather than waiting until they are in distress.

Reinforce the rationale for pulmonary rehabilitation, such as breathing exercises, effective coughing, and general conditioning. Pursed-lip and diaphragmatic breathing strengthen respiratory muscles, minimize small-airway collapse, and control dyspnea. Conditioning exercises increase activity tolerance, muscle strength, and well-being, and reduce respiratory symptoms, anxiety, and depression.

Stress oral care and dental hygiene. Respiratory tract defenses can be impaired by malnutrition, smoking, COPD, diabetes, or corticosteroids. Proper oral care decreases bacterial growth in the mouth that can lead to pulmonary infection.

Discuss avoiding people with active respiratory infections, and stress routine influenza and pneumococcal vaccination. Infections drive exacerbations. The pneumococcal vaccine should be offered to all clients older than 65 years or to any client with an FEV1 less than 40% of predicted, and the influenza vaccine should be given annually to all COPD clients.

Review the harmful effects of smoking and advise cessation by the client and caregivers. Cessation may slow or halt progression. Support groups and medical monitoring may be needed, and second-hand smoke can be as harmful as smoking. Nicotine replacement reduces withdrawal symptoms; nicotine polacrilex gum (Nicorette) beats counseling alone, and transdermal nicotine patches have long-term success rates of 22 to 42%.

Provide information on activity limitations, alternating activity with rest, and energy conservation (pulling instead of pushing, sitting instead of standing), plus pursed-lip breathing, side-lying position, and possible supplemental oxygen during sexual activity. This lets clients make informed choices to reduce dyspnea, maximize activity, and prevent complications.

Instruct the asthmatic client in the use of a peak flow meter as appropriate. Peak flow can drop before symptoms appear after exposure to a trigger, so regular use allows earlier intervention. A peak flow meter with a short symptom questionnaire is inexpensive and easy and can support diagnosis when good-quality spirometry is unavailable.

Discuss respiratory medications, side effects, and adverse reactions. Clients are often on several respiratory drugs with similar side effects and potential interactions. Teach the difference between nuisance side effects (continue the medication) and adverse effects (medication possibly stopped or dose changed).

Demonstrate metered-dose inhaler (MDI) technique, including how to hold it, taking 2 to 5 minutes between puffs, and cleaning it. Proper technique improves delivery and effectiveness. Demonstrate when prescribing a device and recheck technique at each visit.

Set up a system for recording prescribed intermittent drug and inhaler use. This reduces improper use and overdosage of as-needed medications, especially during exacerbations when cognition may be impaired. Logs or diaries, morning-routine pairing, and visual cues such as fixed inhaler locations all help.

Recommend avoiding sedative antianxiety agents unless specifically prescribed or approved by the provider treating the respiratory condition. These can depress respiratory drive and protective cough mechanisms. They may be used prophylactically when the client cannot avoid stress that triggers a respiratory response.

Discuss herbal medications, especially with multiple respiratory medications. Many interactions occur between herbals and respiratory drugs. Effects can be dangerous or lethal in large doses or combinations. Ephedra should be used only in very small doses for a short time. Echinacea can alter drug actions and is not recommended for people with HIV, multiple sclerosis, or other autoimmune diseases.

Review oxygen requirements and dosage for a client discharged on supplemental oxygen. Discuss safe use and refer to the supplier as indicated. This reduces the risk of misuse and complications and promotes safety. Oxygen therapy is generally safe; the survival and quality-of-life benefits of long-term oxygen outweigh the possible risks of oxygen toxicity.

Instruct the client and caregivers in noninvasive positive pressure ventilation (NIPPV) as appropriate. Problem-solve side effects and identify warning signs (increased dyspnea, fatigue, daytime drowsiness, headaches on awakening). NIPPV may be used at night or periodically during the day to decrease CO2 levels, improve sleep quality, and enhance daytime function. Rising CO2 signs indicate the need for more aggressive therapy. Positive pressure helps hypercapnic respiratory failure by decreasing the work of breathing and improving alveolar ventilation.

Provide information and encourage participation in support groups (American Lung Association, public health department). Clients and caregivers face anxiety, depression, and other reactions in living with a chronic disease. Support groups and home visits provide assistance, emotional support, and respite care.

Refer for home care evaluation if indicated. Provide a detailed care plan and baseline physical assessment to the home care nurse on discharge. This provides continuity and may reduce rehospitalization. Self-management education supported by a case manager, with or without a written action plan, is recommended to prevent exacerbation complications such as hospital admissions.

Frequently Asked Questions

How is COPD diagnosed? Diagnosis requires forced spirometry. A post-bronchodilator FEV1/FVC ratio below 0.7 confirms persistent airflow limitation, and the GOLD 2025 report calls this measurement mandatory. Suspect COPD in any patient with chronic dyspnea, cough, sputum production, recurrent lower respiratory infections, or exposure to risk factors such as tobacco smoke or biomass fuels.

What are the GOLD severity grades? Once the FEV1/FVC ratio confirms obstruction, severity is graded on post-bronchodilator FEV1 percent predicted: GOLD 1 mild (FEV1 at or above 80%), GOLD 2 moderate (50 to 79%), GOLD 3 severe (30 to 49%), and GOLD 4 very severe (below 30%).

What is the priority nursing assessment in a COPD exacerbation? Airway patency and gas exchange. Monitor respiratory rate and depth, breath sounds, accessory muscle use, mental status, and SpO2. ABG analysis gives the best read on the severity of an exacerbation, and rising confusion or somnolence with worsening gases points to CO2 retention and respiratory failure.

Why is oxygen titrated to 88 to 92% in COPD? Many patients with advanced COPD are chronic CO2 retainers, so over-oxygenation can blunt respiratory drive and worsen hypercapnia. Titrating supplemental oxygen to an SpO2 of 88 to 92% delivers enough oxygen to protect tissues while reducing the risk of CO2 narcosis.

What is the single most effective intervention for COPD? Smoking cessation. It has the greatest power to change the natural history of the disease by slowing the decline in lung function. Pair cessation counseling with pharmacologic support, since smokers decline faster and have higher mortality than non-smokers.

Which vaccines do COPD patients need? Give the inactivated influenza vaccine annually to all COPD patients. Offer the pneumococcal vaccine to all patients older than 65 and to any patient with an FEV1 below 40% of predicted. Both reduce exacerbations, hospitalizations, and serious outcomes.